A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. We offer our Customers a unique mix of innovative products and services. These include: consumable products, such as detergents, endoscopy accessories, barrier products, instruments and tools; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair, laboratory testing, and outsourced reprocessing; capital equipment, such as sterilizers, surgical tables, and automated endoscope reprocessors; and connectivity solutions such as operating room (“OR”) integration. We operate and report our financial information in three reportable business segments: Healthcare, Applied Sterilization Technologies ("AST"), and Life Sciences.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 5.8B | 5.5B | 5.1B | 4.5B | 4.6B | 3.1B |
| Net Income | 708M | 615M | 378M | 107M | 244M | 397M |
| EPS | $7.16 | $6.20 | $3.81 | $1.07 | $2.48 | $4.63 |
| Free Cash Flow | 917M | 778M | 613M | 395M | 397M | 450M |
| ROIC | 9.2% | 7.4% | 6.9% | 7.1% | 3.5% | 9.1% |
| Gross Margin | 44.1% | 44.0% | 43.2% | 43.7% | 44.0% | 43.2% |
| Debt/Equity | 0.27 | 0.33 | 0.54 | 0.53 | 0.50 | 0.49 |
| Dividends/Share | $2.41 | $2.23 | $2.03 | $1.84 | $1.69 | $1.57 |
| Operating Income | 1.0B | 867M | 836M | 791M | 426M | 548M |
| Operating Margin | 17.2% | 15.9% | 16.3% | 17.4% | 9.3% | 17.6% |
| ROE | 9.9% | 9.5% | 6.0% | 1.8% | 3.7% | 10.9% |
| Shares Outstanding | 98M | 99M | 99M | 100M | 98M | 86M |
STERIS plc passes 3 of 9 quality checks, indicating weak fundamentals.
STERIS plc trades at 31.4x trailing earnings, compared to its 15-year median P/E of 35.7x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 24.0x vs a median of 32.2x. The company's 5-year average ROIC is 6.8% with a gross margin of 43.6%. Total shareholder yield (dividends + buybacks) is 1.8%. At current prices, the estimated annualized return to fair value is +10.2%.
STERIS plc (STE) has a current P/E ratio of 31.4, compared to its historical median P/E of 35.7. The stock is currently considered Fair based on its historical valuation range.
STERIS plc (STE) has a 5-year average return on invested capital (ROIC) of 6.8%. This is below average and may indicate limited pricing power.
STERIS plc (STE) has a market capitalization of $22.1B. It is classified as a large-cap stock.
Yes, STERIS plc (STE) pays a dividend with a trailing twelve-month yield of 1.07%. The company also returns capital through share buybacks, with a buyback yield of 0.73%.
Based on historical P/E analysis, STERIS plc (STE) appears fair. The current P/E of 31.4 is 12% below its historical median of 35.7. The estimated fair value CAGR (P/E method) is 2.2%.
STERIS plc (STE) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, within the Healthcare sector.
STERIS plc (STE) reported annual revenue of $5.5 billion in its most recent fiscal year, based on SEC EDGAR filings.
STERIS plc (STE) has a net profit margin of 11.3%. This is a healthy margin.
STERIS plc (STE) generated $778 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
STERIS plc (STE) has a debt-to-equity ratio of 0.33. This indicates a conservatively financed balance sheet.
STERIS plc (STE) reported earnings per share (EPS) of $6.20 in its most recent fiscal year.
STERIS plc (STE) has a return on equity (ROE) of 9.5%. This indicates moderate shareholder returns.
STERIS plc (STE) has a 5-year average gross margin of 43.6%. This indicates decent pricing power.
The Ledger Terminal provides 9 years of financial data for STERIS plc (STE), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
STERIS plc (STE) has a book value per share of $66.61, based on its most recent annual SEC filing.
No recent press releases.